Sept 17 (Reuters) - Sienna Biopharmaceuticals Inc SNNA.O :
* SIENNA BIOPHARMACEUTICALS - ON SEPTEMBER 16, PRIOR TO
FILING
CHAPTER 11 MADE PAYMENT TO SILICON VALLEY BANK OF $21.3 MILLION
* SIENNA BIOPHARMACEUTICALS - IN ANTICIPATION OF CHAPTER 11
PROCEEDING, COMPANY IMPLEMENTED A CORPORATE RESTRUCTURING
* SIENNA BIOPHARMACEUTICALS - ESTIMATES INCURRING ONE-TIME
EMPLOYEE BENEFITS & SEVERANCE CHARGE OF ABOUT $1.3 MILLION IN Q3
2019 RELATED TO RESTRUCTURING
* SIENNA BIOPHARMACEUTICALS INC - RESTRUCTURING RESULTED IN
AN
IMMEDIATE ELIMINATION OF 7 POSITIONS
* SIENNA BIOPHARMACEUTICALS INC - ON SEPT 11, BOARD OF
APPROVED A
MANAGEMENT RETENTION PLAN AND KEY EMPLOYEE INCENTIVE BONUS PLAN
Source: (https://bit.ly/2kQrr3H)
Further company coverage: SNNA.O
((Reuters.Briefs@thomsonreuters.com;))